Blocking TMEM141 Reduces MASH and Fibrosis Through ROS-HNF4α Pathway
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
A groundbreaking study has unveiled a promising therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis, two increasingly prevalent ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine